Musaffa Logo
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD CURE.L

Is VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD Halal?

Shariah Compliance Analysis of CURE.L ETF

No. As of October 2026, VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE.L) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology.

CURE.L was created on 2022-09-02 by VanEck. The fund's investment portfolio concentrates primarily on theme equity. The Funds investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries

CURE.L Shariah Compliance

As of October 2026, VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is classified as not halal.

NOT HALAL

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE.L) Chart

Fetching Price Chart...